H.U. Group Holdings Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van H.U. Group Holdings is gedaald met een gemiddeld jaarlijks percentage van -12.8%, terwijl de winst van de Healthcare -industrie jaarlijks groeide met 6.7%. De inkomsten zijn groeide met een gemiddeld percentage van 5.7% per jaar.

Belangrijke informatie

-12.8%

Groei van de winst

-12.8%

Groei van de winst per aandeel

Healthcare Groei van de industrie	7.9%
Inkomstengroei	5.7%
Rendement op eigen vermogen	-4.8%
Nettomarge	-2.7%
Laatste winstupdate	30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Analysts Have Been Trimming Their H.U. Group Holdings, Inc. (TSE:4544) Price Target After Its Latest Report

Jun 24

Does H.U. Group Holdings (TSE:4544) Have A Healthy Balance Sheet?

Jun 21

H.U. Group Holdings, Inc.'s (TSE:4544) Intrinsic Value Is Potentially 54% Above Its Share Price

Feb 28

Opbrengsten en kosten

Hoe H.U. Group Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

TSE:4544 Opbrengsten, kosten en inkomsten (JPY Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
30 Sep 24	240,394	-6,552	48,633	11,262
30 Jun 24	238,672	-7,052	66,573	0
31 Mar 24	236,950	-7,553	50,046	11,262
31 Dec 23	237,456	-6,458	52,055	9,556
30 Sep 23	243,370	-1,699	52,165	9,556
30 Jun 23	252,197	8,969	51,944	9,556
31 Mar 23	260,908	15,676	51,572	9,556
31 Dec 22	276,026	22,870	56,921	7,281
30 Sep 22	273,286	25,633	55,780	7,281
30 Jun 22	274,783	26,843	54,370	7,281
31 Mar 22	272,944	29,599	51,184	7,281
31 Dec 21	259,808	30,266	48,701	5,944
30 Sep 21	258,189	31,885	46,483	5,944
30 Jun 21	242,604	27,194	43,795	5,944
31 Mar 21	223,016	17,468	42,090	5,944
31 Dec 20	207,955	9,077	40,513	5,514
30 Sep 20	193,798	2,042	39,230	5,514
30 Jun 20	186,332	-3,054	39,182	5,514
31 Mar 20	188,712	-516	39,421	5,514
31 Dec 19	188,014	2,733	39,142	5,937
30 Sep 19	185,231	4,457	38,290	5,937
30 Jun 19	182,727	5,697	38,028	5,937
31 Mar 19	181,415	6,386	38,900	5,937
31 Dec 18	178,473	886	38,453	5,365
30 Sep 18	181,159	9,801	41,683	5,365
30 Jun 18	188,204	-2,499	43,967	5,365
31 Mar 18	195,400	257	45,081	5,365
31 Dec 17	202,563	6,272	44,774	4,748
30 Sep 17	205,497	359	42,628	4,748
30 Jun 17	204,346	2,948	41,007	4,748
31 Mar 17	204,245	333	40,603	4,748
31 Dec 16	206,217	5,091	38,572	5,702
30 Sep 16	208,413	-16,703	39,755	5,702
30 Jun 16	211,076	-7,065	41,333	5,702
31 Mar 16	211,743	-5,081	41,878	5,702
31 Dec 15	209,940	-7,471	41,747	5,384
30 Sep 15	208,432	14,365	41,694	5,384
30 Jun 15	206,193	16,713	40,687	5,384
31 Mar 15	204,667	16,002	40,047	5,384
31 Dec 14	204,911	16,454	41,518	5,412
30 Sep 14	204,342	14,813	42,402	5,412
30 Jun 14	203,997	14,350	43,085	5,412
31 Mar 14	203,371	15,322	43,351	5,412
31 Dec 13	200,277	15,391	43,295	5,077

Kwaliteitswinsten: 4544 is momenteel verliesgevend.

Groeiende winstmarge: 4544 is momenteel verliesgevend.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: 4544 is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 12.8% per jaar.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van 4544 over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: 4544 is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Healthcare industrie ( 5.1% ).

Rendement op eigen vermogen

Hoge ROE: 4544 heeft een negatief Return on Equity ( -4.81% ), omdat het momenteel verliesgevend is.

H.U. Group Holdings Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

H.U. Group Holdings, Inc. to Report Q2, 2025 Results on Nov 08, 2024

H.U. Group Holdings, Inc. to Report Q1, 2025 Results on Aug 08, 2024

Full year 2024 earnings: EPS misses analyst expectations

Full year 2024 earnings: EPS misses analyst expectations

H.U. Group Holdings, Inc. to Report Fiscal Year 2024 Results on May 10, 2024

Recent updates

Now 21% undervalued after recent price drop

Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00

Upcoming dividend of JP¥62.00 per share

H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00

H.U. Group Holdings, Inc. to Report Q2, 2025 Results on Nov 08, 2024

H.U. Group Holdings (TSE:4544) Is Due To Pay A Dividend Of ¥62.00

Estimating The Fair Value Of H.U. Group Holdings, Inc. (TSE:4544)

Now 25% undervalued

Price target decreased by 8.1% to JP¥2,314

H.U. Group Holdings, Inc. and Fujirebio Launches the Fully Automated Lumipulse G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu

H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00

H.U. Group Holdings' (TSE:4544) Dividend Will Be ¥62.00

Final dividend of JP¥62.00 announced

H.U. Group Holdings, Inc. to Report Q1, 2025 Results on Aug 08, 2024

Analysts Have Been Trimming Their H.U. Group Holdings, Inc. (TSE:4544) Price Target After Its Latest Report

Full year 2024 earnings: EPS misses analyst expectations

Does H.U. Group Holdings (TSE:4544) Have A Healthy Balance Sheet?

Full year 2024 earnings: EPS misses analyst expectations

H.U. Group Holdings, Inc., Annual General Meeting, Jun 18, 2024

Now 21% undervalued after recent price drop

H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Chief Financial Officer

H.U. Group Holdings, Inc. to Report Fiscal Year 2024 Results on May 10, 2024

Upcoming dividend of JP¥63.00 per share

H.U. Group Holdings, Inc.'s (TSE:4544) Intrinsic Value Is Potentially 54% Above Its Share Price

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

H.U. Group Holdings, Inc. to Report Q3, 2024 Results on Feb 09, 2024

H.U. Group Holdings Inc. and Fujirebio Announces the Availability of the Lumipulse G pTau 217 Plasma Assay for the Fully Automated LUMIPULSE G Immunoassay Systems

H.U. Group Holdings, Inc. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 30%

Price target decreased by 9.4% to JP¥2,727

Upcoming dividend of JP¥62.00 per share at 4.7% yield

H.U. Group Holdings, Inc.(TSE:4544) dropped from FTSE All-World Index (USD)

H.U. Group Holdings, Inc.(TSE:4544) dropped from FTSE All-World Index (USD)

H.U. Group Holdings, Inc. to Report Q2, 2024 Results on Nov 09, 2023

Consensus EPS estimates increase by 17%

First quarter 2024 earnings released: JP¥19.66 loss per share (vs JP¥98.23 profit in 1Q 2023)

Now 20% undervalued after recent price drop

H.U. Group Holdings, Inc. to Report Q1, 2024 Results on Aug 08, 2023

Full year 2023 earnings: EPS misses analyst expectations

H.U. Group Holdings, Inc. Announces Dividend for the Year Ended March 31, 2023, Payable on May 30, 2023; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024

Full year 2023 earnings: EPS misses analyst expectations

H.U. Group Holdings, Inc., Annual General Meeting, Jun 20, 2023

Upcoming dividend of JP¥63.00 per share at 4.7% yield

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: JP¥56.86 (vs JP¥105 in 3Q 2022)

H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2023

H.U. Group Holdings, Inc. to Report Q3, 2023 Results on Feb 08, 2023

Second quarter 2023 earnings released: EPS: JP¥175 (vs JP¥196 in 2Q 2022)

Second quarter 2023 earnings released: EPS: JP¥175 (vs JP¥196 in 2Q 2022)

Upcoming dividend of JP¥62.00 per share

H.U. Group Holdings, Inc. to Report Q2, 2023 Results on Nov 09, 2022

Consensus forecasts updated

H.U. Group Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

First quarter 2023 earnings released: EPS: JP¥98.23 (vs JP¥146 in 1Q 2022)

Now 20% undervalued

Price target decreased to JP¥3,137

Now 21% undervalued

Full year 2022 earnings: Revenues exceed analyst expectations

Price target decreased to JP¥3,055

Now 20% undervalued after recent price drop

H.U. Group Holdings, Inc. to Report Q1, 2023 Results on Aug 09, 2022

Consensus EPS estimates increase by 27%

H.U. Group Holdings, Inc. Provides Dividend Guidance for the Fiscal Year Ended March 31, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

H.U. Group Holdings, Inc., Annual General Meeting, Jun 21, 2022

Insufficient new directors